Glucose B.Braun

Glucose B.Braun is an intravenous solution containing glucose monohydrate as the active ingredient, supplied in a sterile solution for injection. It is a parenteral carbohydrate preparation used in the European market for fluid replacement, parenteral nutrition, and correction of low blood glucose. The product is prescription‑only and administered by healthcare professionals. It is formulated to provide rapid energy substrate and to support electrolyte balance during acute care.

Glucose B.Braun is indicated for several clinical situations where rapid provision of glucose and fluid is required.

- Treatment of hypoglycemia in adults and children when oral glucose is not feasible. - Intravenous fluid and electrolyte replacement in patients unable to tolerate oral intake. - Component of parenteral nutrition regimens to meet carbohydrate caloric needs. - Support during surgical procedures or critical illness to maintain blood glucose levels. - Dilution medium for certain intravenous medications requiring a compatible carbohydrate carrier.

When administered intravenously, Glucose B.Braun may be associated with a range of observed effects, most of which are mild and transient.

Common: - Hyperglycemia (elevated blood glucose). - Local irritation at the infusion site. - Nausea or vomiting. - Fluid overload in patients with compromised cardiac function.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Hypotension due to rapid infusion. - Allergic or anaphylactic reaction. - Electrolyte disturbances such as hypernatremia.

Safe use of Glucose B.Braun requires attention to patient condition, infusion rate, and compatibility with other therapies.

- Assess blood glucose and adjust infusion to avoid hyperglycemia. - Use caution in patients with diabetes mellitus, renal impairment, or heart failure. - Monitor fluid balance and electrolytes during prolonged administration. - Verify compatibility with other intravenous drugs; avoid mixing with calcium‑containing solutions. - Ensure aseptic technique to prevent catheter‑related infections. - Adjust dose in pediatric patients based on weight and metabolic needs.

Glucose B.Braun can interact with certain medications or solutions, influencing efficacy or safety.

Avoid: - Co‑administration with insulin infusions without appropriate dose adjustments. - Mixing with calcium or phosphate solutions that may precipitate. - Concurrent use with hypertonic dextrose solutions leading to excessive carbohydrate load.

Use with caution: - Concurrent diuretics that may exacerbate fluid shifts. - Beta‑blockers that can mask signs of hypoglycemia. - Vasopressors, as rapid glucose infusion may affect hemodynamic stability.